chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Musculoskeletal stiffness
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of injection site pain (pain in the injection site) and musculoskeletal stiffness (kind of stiffness) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included no adverse event. No reported medical history. On Jan 20, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced injection site pain (pain in the injection site) and musculoskeletal stiffness (kind of stiffness). At the time of the report, injection site pain (pain in the injection site) and musculoskeletal stiffness (kind of stiffness) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications or treatment information reported.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Pharyngeal swelling, Throat irritation
Clinical narrative: random  pricks on her body; arms started tingling, both her left and right arm; throat scratchy, very itchy and like it could be a little swollen; throat scratchy, very itchy and like it could be a little swollen; pins and needles on her arm  that went from there to her whole body; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (arms started tingling, both her left and right arm), THROAT IRRITATION (throat scratchy, very itchy and like it could be a little swollen), PHARYNGEAL SWELLING (throat scratchy, very itchy and like it could be a little swollen), PARAESTHESIA (pins and needles on her arm  that went from there to her whole body) and PARAESTHESIA (random  pricks on her body) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction (no adverse reaction reported).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced PARAESTHESIA (arms started tingling, both her left and right arm), THROAT IRRITATION (throat scratchy, very itchy and like it could be a little swollen), PHARYNGEAL SWELLING (throat scratchy, very itchy and like it could be a little swollen) and PARAESTHESIA (pins and needles on her arm  that went from there to her whole body). On 17-Jan-2021, the patient experienced PARAESTHESIA (random  pricks on her body). On 14-Jan-2021, PARAESTHESIA (arms started tingling, both her left and right arm), THROAT IRRITATION (throat scratchy, very itchy and like it could be a little swollen) and PHARYNGEAL SWELLING (throat scratchy, very itchy and like it could be a little swollen) outcome was unknown. On 17-Jan-2021, PARAESTHESIA (pins and needles on her arm  that went from there to her whole body) outcome was unknown. At the time of the report, PARAESTHESIA (random  pricks on her body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Malaise, Pyrexia
Clinical narrative: Fever of 106 deg. F; Not feeling well; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 106 deg. F) and MALAISE (Not feeling well) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported.).    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced PYREXIA (Fever of 106 deg. F) and MALAISE (Not feeling well). At the time of the report, PYREXIA (Fever of 106 deg. F) and MALAISE (Not feeling well) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jan-2021, Body temperature: 106 deg f (High) The patient has fever..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications reported. No treatment information provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: Ring worm like reaction at the injection site; A spontaneous report was received from a consumer of unspecified age and gender, who received Moderna's COVID-19 Vaccine (mRNA-1273) and developed ring worm like reaction at the injection site.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On an unknown date the patient received first of two planned doses of mRNA-1273 (batch number unknown) for prophylaxis of COVID-19 infection.   On an unknown date, ten days after vaccination the patient developed a ring worm like reaction at the injection site.  Action taken with mRNA-1273 in response to the event was unknown.   The outcome of event ring worm like reaction at the injection site was unknown at the time of this report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Injection site bruising, Injection site pruritus, Injection site swelling
Clinical narrative: bruising at injection site; itching at the injection site; Swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of   in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications reported. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling
Clinical narrative: swelling; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE SWELLING (swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced INJECTION SITE SWELLING (swelling). At the time of the report, INJECTION SITE SWELLING (swelling) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications reported. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site cellulitis, Injection site pruritus, Pain in extremity, Pruritus
Clinical narrative: swelling, erythema, hot to touch; expanded skin that looks like cellulitus; little itchiness; little itchiness; swelling; erythema; arm soreness; This spontaneous case was reported by a physician and describes the occurrence of   in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. N/A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included AMOXICILLIN from 23-Jan-2021 to an unknown date for Antibiotic level, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HYDROCHLOROTHIAZIDE ACTAVIS) for Hypertension.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included Zyzal
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: swelling, erythema, hot to touch; expanded skin that looks like cellulitus; little itchiness; little itchiness; swelling; erythema; arm soreness; This spontaneous case was reported by a physician and describes the occurrence of   in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. N/A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included AMOXICILLIN from 23-Jan-2021 to an unknown date for Antibiotic level, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HYDROCHLOROTHIAZIDE ACTAVIS) for Hypertension.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included Zyzal
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Pain in extremity, Pyrexia
Clinical narrative: was tested positive for Covid; had fever; was tired; sore left arm; A spontaneous report was received from a consumer concerning a 62-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273)  experienced sore left arm, had fever, was tired, was tested positive for Covid.   The patient's medical history was not provided. Concomitant medications reported were calcium.   On 13/Jan/2021 prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.     On 14/Jan/2021, the patient experienced sore left arm. On 22-JAN-2021 the patient experienced had fever and was tired. On 24/Jan/2021 the patient experienced was tested positive for Covid.  Treatment medications were not reported.   Action taken with mRNA-1273 in response to the events was not reported.     The events, sore left arm, was considered resolved on 24 Dec 2020. The outcome of the events had fever, was tired, was tested positive for Covid was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of pain in arm, pyrexia and fatigue, a causal relationship cannot be excluded.  Based on the current available information and the mechanism of action of mRNA-1237 vaccine, the event of COVID-19 is assessed as unlikely related.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Vaccination site pain
Clinical narrative: Injection site arm got sore; Very fatigued; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Injection site arm got sore), FATIGUE (Very fatigued) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced FATIGUE (Very fatigued) and HEADACHE (Headache). On an unknown date, the patient experienced VACCINATION SITE PAIN (Injection site arm got sore). At the time of the report, VACCINATION SITE PAIN (Injection site arm got sore), FATIGUE (Very fatigued) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dysgeusia, Feeling hot, Pain, Vaccination site pain
Clinical narrative: Odd taste in mouth; Body aches; Feverish feeling with no temperature; Chills; Injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Odd taste in mouth), PAIN (Body aches), FEELING HOT (Feverish feeling with no temperature), CHILLS (Chills) and VACCINATION SITE PAIN (Injection site pain) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. El1284) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced DYSGEUSIA (Odd taste in mouth), PAIN (Body aches), FEELING HOT (Feverish feeling with no temperature), CHILLS (Chills) and VACCINATION SITE PAIN (Injection site pain). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 09-Jan-2021, PAIN (Body aches) and CHILLS (Chills) had resolved. On 10-Jan-2021, VACCINATION SITE PAIN (Injection site pain) had resolved. At the time of the report, DYSGEUSIA (Odd taste in mouth) and FEELING HOT (Feverish feeling with no temperature) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided
Sex: F
Vaccine: COVID19
Symptoms: Chills, Illness, Pyrexia
Clinical narrative: very sick; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very sick), CHILLS (chills) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (very sick), CHILLS (chills) and PYREXIA (fever). At the time of the report, ILLNESS (very sick), CHILLS (chills) and PYREXIA (fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment related information has been reported.    Reporter did not allow further contact; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: mildly sore on the arms on injection site; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (mildly sore on the arms on injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (mildly sore on the arms on injection site). At the time of the report, VACCINATION SITE PAIN (mildly sore on the arms on injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VERTIGO (Vertigo). At the time of the report, VERTIGO (Vertigo) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided Treatment information provided as "used pills for vertigo"
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Limb discomfort
Clinical narrative: I couldn't move my arm; Hurting all the way into my shoulder blade; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (I couldn't move my arm) and ARTHRALGIA (Hurting all the way into my shoulder blade) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced LIMB DISCOMFORT (I couldn't move my arm) and ARTHRALGIA (Hurting all the way into my shoulder blade). At the time of the report, LIMB DISCOMFORT (I couldn't move my arm) and ARTHRALGIA (Hurting all the way into my shoulder blade) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: big red at the injection site; swollen at the injection site; tenderness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (big red at the injection site), INJECTION SITE SWELLING (swollen at the injection site) and INJECTION SITE PAIN (tenderness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 21-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (big red at the injection site), INJECTION SITE SWELLING (swollen at the injection site) and INJECTION SITE PAIN (tenderness). At the time of the report, INJECTION SITE ERYTHEMA (big red at the injection site), INJECTION SITE SWELLING (swollen at the injection site) and INJECTION SITE PAIN (tenderness) outcome was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Chills; A spontaneous report was received from a Consumer concerning patient of a unknown Age and gender who received Modern's COVID-19 vaccine (mRNA-1273) and experienced Chills.  The patient's medical history was not provided.  concomitant medication details were not provided.  On unknown date, prior to the onset of the events, the patient received their second dose of two planned doses of mRNA-1273 (lot/batch: unknown).  On unknown date, the patient experienced the events of Chills.  No Laboratory details provided.  No treatment information was provided   Action taken with mRNA-1273 in response to the events was not reported.  At the time of this report, the outcome of the events Chills is recovered.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain in extremity, Vaccination site erythema, Vaccination site pain
Clinical narrative: Sore arm; Rash at the injection site; Nausea; Headache; red at the injection site.; itchy at the injection site; It was sore to touch/ injection site tenderness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE PAIN (It was sore to touch/ injection site tenderness), VACCINATION SITE RASH (Rash at the injection site) and NAUSEA (Nausea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history reported.).    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchy at the injection site) and VACCINATION SITE PAIN (It was sore to touch/ injection site tenderness). On 15-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash at the injection site), NAUSEA (Nausea), HEADACHE (Headache) and VACCINATION SITE ERYTHEMA (red at the injection site.). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE PAIN (It was sore to touch/ injection site tenderness), VACCINATION SITE RASH (Rash at the injection site), NAUSEA (Nausea), HEADACHE (Headache) and VACCINATION SITE ERYTHEMA (red at the injection site.) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: Sore arm; Rash at the injection site; Nausea; Headache; red at the injection site.; itchy at the injection site; It was sore to touch/ injection site tenderness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE PAIN (It was sore to touch/ injection site tenderness), VACCINATION SITE RASH (Rash at the injection site) and NAUSEA (Nausea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history reported.).    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchy at the injection site) and VACCINATION SITE PAIN (It was sore to touch/ injection site tenderness). On 15-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash at the injection site), NAUSEA (Nausea), HEADACHE (Headache) and VACCINATION SITE ERYTHEMA (red at the injection site.). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm), VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE PAIN (It was sore to touch/ injection site tenderness), VACCINATION SITE RASH (Rash at the injection site), NAUSEA (Nausea), HEADACHE (Headache) and VACCINATION SITE ERYTHEMA (red at the injection site.) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: Chills; fever going from 99 to 100 and back down again; very achy; A Spontaneous report was reported was received from concerning a 78 years old, male patient who was administered by Modern's COVID-19 vaccine and an adverse event was reported.  The patient's medical history was not known and patient is having questions regarding the use of Tylenol whether they should take it or what they can do.  On 22 Jan 2021 ,of morning  both patient and his wife received Moderna vaccine.   On 23rd JAN  2021 patient reported severe chills and has a fever which went from 99 to 100 back down again . Patient was confused and don't know what to do. They both were very achy. Lot number 20A (patient didn't provided the rest of the lot number.  No treatment information was provided.  The adverse event ,reported by the patient was considered to be resolved.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Headache, Myalgia, Neck pain, Pain
Clinical narrative: Throbbing feeling between temples; Pressure in head; Pain; Terrible headache; Aches; Barely turn neck; This spontaneous case was reported by a non-health professional and describes the occurrence of NECK PAIN (Barely turn neck), PAIN (Throbbing feeling between temples), HEAD DISCOMFORT (Pressure in head), PAIN (Pain) and HEADACHE (Terrible headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced NECK PAIN (Barely turn neck), PAIN (Pain), HEADACHE (Terrible headache) and MYALGIA (Aches). On 12-Jan-2021, the patient experienced PAIN (Throbbing feeling between temples) and HEAD DISCOMFORT (Pressure in head). The patient was treated with IBUPROFEN ongoing since an unknown date for Adverse event, at a dose of UNK dosage form and PARACETAMOL (TYLENOL) ongoing since an unknown date for Adverse event, at a dose of UNK dosage form. At the time of the report, NECK PAIN (Barely turn neck), PAIN (Throbbing feeling between temples), HEAD DISCOMFORT (Pressure in head), PAIN (Pain), HEADACHE (Terrible headache) and MYALGIA (Aches) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site induration, Vaccination site rash, Vaccination site swelling
Clinical narrative: Itchiness; knot; minor rash; swollen arm at injection site; WARNING: THE STUDY CONFIGURATION IS MISSING THE STUDY PHASE. PLEASE UPDATE THE STUDY PHASE AND RE-GENERATE THE NARRATIVE AGAIN.    This     The subject received mRNA-1273 (Moderna COVID-19 Vaccine). The report describes a case of PRURITUS (Itchiness), VACCINATION SITE INDURATION (knot), VACCINATION SITE RASH (minor rash) and VACCINATION SITE SWELLING (swollen arm at injection site).     No Medical History information was reported.  On an unknown date, the patient experienced PRURITUS (Itchiness), VACCINATION SITE INDURATION (knot), VACCINATION SITE RASH (minor rash) and VACCINATION SITE SWELLING (swollen arm at injection site). At the time of the report, PRURITUS (Itchiness), VACCINATION SITE INDURATION (knot), VACCINATION SITE RASH (minor rash) and VACCINATION SITE SWELLING (swollen arm at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Treatment included ice and heat.
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine
Clinical narrative: got delayed allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (got delayed allergic reaction) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ALLERGY TO VACCINE (got delayed allergic reaction). At the time of the report, ALLERGY TO VACCINE (got delayed allergic reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Spreading and itchy; Red, Oval Itching spot at injection site; Little rise in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (Spreading and itchy), INJECTION SITE ERYTHEMA (Red, Oval Itching spot at injection site) and INJECTION SITE SWELLING (Little rise in the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced INJECTION SITE PRURITUS (Spreading and itchy), INJECTION SITE ERYTHEMA (Red, Oval Itching spot at injection site) and INJECTION SITE SWELLING (Little rise in the injection site). At the time of the report, INJECTION SITE PRURITUS (Spreading and itchy), INJECTION SITE ERYTHEMA (Red, Oval Itching spot at injection site) and INJECTION SITE SWELLING (Little rise in the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: a little sore arm; arm hurting, swollen; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (a little sore arm) and INJECTION SITE SWELLING (arm hurting, swollen) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) and DULAGLUTIDE (TRULICITY) for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (a little sore arm) and INJECTION SITE SWELLING (arm hurting, swollen). At the time of the report, INJECTION SITE PAIN (a little sore arm) had not resolved and INJECTION SITE SWELLING (arm hurting, swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Migraine with aura
Clinical narrative: Terrible migraine headaches with aura; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE WITH AURA (Terrible migraine headaches with aura) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Tetracycline, Clindamycin).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE WITH AURA (Terrible migraine headaches with aura). At the time of the report, MIGRAINE WITH AURA (Terrible migraine headaches with aura) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Injection site discolouration, Injection site erythema
Clinical narrative: Big circle around the injection site; red (circle); This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE DISCOLOURATION (Big circle around the injection site) and INJECTION SITE ERYTHEMA (red (circle)) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE DISCOLOURATION (Big circle around the injection site) and INJECTION SITE ERYTHEMA (red (circle)). At the time of the report, INJECTION SITE DISCOLOURATION (Big circle around the injection site) and INJECTION SITE ERYTHEMA (red (circle)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Signs and symptoms/reaction to the moderna shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Signs and symptoms/reaction to the moderna shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION COMPLICATION (Signs and symptoms/reaction to the moderna shot). At the time of the report, VACCINATION COMPLICATION (Signs and symptoms/reaction to the moderna shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Tremor
Clinical narrative: shaking; fever; arm started to hurt; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (arm started to hurt), TREMOR (shaking) and PYREXIA (fever) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LOSARTAN, DICLOFENAC SODIUM, LINUM USITATISSIMUM, MENTHOL, METHYL SALICYLATE, THIOCOLCHICOSIDE (INSTAFLEX) and CETIRIZINE HYDROCHLORIDE (ALLERTEC) for an unknown indication.    On 31-Jan-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm started to hurt). On 01-Feb-2021, the patient experienced TREMOR (shaking) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm started to hurt) and TREMOR (shaking) outcome was unknown and PYREXIA (fever) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Myalgia, Nasopharyngitis, Pyrexia
Clinical narrative: COVID 19; body aches; fever; cold symptoms; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold symptoms), COVID-19 (COVID 19), MYALGIA (body aches) and PYREXIA (fever) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced NASOPHARYNGITIS (cold symptoms), MYALGIA (body aches) and PYREXIA (fever). On 24-Jan-2021, the patient experienced COVID-19 (COVID 19). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (cold symptoms), COVID-19 (COVID 19), MYALGIA (body aches) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Mild Headache; Low grade Fever of 100-101ºC; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Mild Headache) and PYREXIA (Low grade Fever of 100-101ºC) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced HEADACHE (Mild Headache) and PYREXIA (Low grade Fever of 100-101ºC). At the time of the report, HEADACHE (Mild Headache) and PYREXIA (Low grade Fever of 100-101ºC) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included Blood pressure. Concomitant products included OLMESARTAN MEDOXOMIL (BENICAR) for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site warmth
Clinical narrative: Redness below injection site; It was hard; Warm; Itchy; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm), VACCINATION SITE ERYTHEMA (Redness below injection site), VACCINATION SITE INDURATION (It was hard), VACCINATION SITE WARMTH (Warm) and PRURITUS (Itchy) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 23-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness below injection site), VACCINATION SITE INDURATION (It was hard), VACCINATION SITE WARMTH (Warm) and PRURITUS (Itchy). The patient was treated with CEFALEXIN (CEPHALEXIN AMEL) ongoing since an unknown date at a dose of 500 mg two times per week. At the time of the report, VACCINATION SITE PAIN (sore arm) had resolved and VACCINATION SITE ERYTHEMA (Redness below injection site), VACCINATION SITE INDURATION (It was hard), VACCINATION SITE WARMTH (Warm) and PRURITUS (Itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: A round circle, was dark red; Feels a bit warm; Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm was sore), VACCINATION SITE ERYTHEMA (A round circle, was dark red) and VACCINATION SITE WARMTH (Feels a bit warm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included Diabetes. Concomitant products included INSULIN GLARGINE (LANTUS), ATORVASTATIN, OLMESARTAN and LEVOTHYROXINE for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm was sore). On 25-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (A round circle, was dark red) and VACCINATION SITE WARMTH (Feels a bit warm). On 16-Jan-2021, VACCINATION SITE PAIN (Arm was sore) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (A round circle, was dark red) and VACCINATION SITE WARMTH (Feels a bit warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (exposure during pregnancy) in a 40-year-old female patient (gravida 5, para 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 024M20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (Casual drinker prior to pregnancy) on 01-Aug-2020, Pregnancy (still birth) on 06-Mar-2002, Pregnancy (Live,Full-term birth) on 16-Jan-2003, Pregnancy (Live, Full-term birth) on 25-Feb-2010 and Pregnancy (Live, Full-term birth) on 22-Sep-2013. Concomitant products included PRENATAL 1+1 FE from 09-Jan-2020 to an unknown date for Pregnancy, IRON (IRON ORAL) from 09-Feb-2021 to an unknown date for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 03-Aug-2020 and the estimated date of delivery was 10-May-2021. On 12-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-third week of the pregnancy.  On 12-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (exposure during pregnancy) had resolved. not provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Sep-2020, Pregnancy test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient underwent glucose tolerance test on 05 Feb 2021 and sonogram 01 Jan 2021, but results were not provided. The number of fetuses was reported as 1 and had established prenatal care. The patient had no complications and acute illness during this pregnancy to date.  The patient had no maternal history of subfertility.  No treatment information was provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Pruritus
Clinical narrative: itchy; swollen 3 inches in size; redness; arm soreness; arm swollen; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness), PERIPHERAL SWELLING (arm swollen), PRURITUS (itchy), PERIPHERAL SWELLING (swollen 3 inches in size) and ERYTHEMA (redness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041620A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN for Cholesterol, ESTRADIOL for Hormone level abnormal, IBUPROFEN for Pain, CYANOCOBALAMIN, FOLIC ACID (VITAMIN B12 & FOLIC ACID), ASCORBIC ACID, BETACAROTENE, CUPRIC OXIDE, TOCOPHERYL ACETATE, ZINC OXIDE (PRESERVISION), CALCIUM, COLECALCIFEROL (CITRACAL CALCIUM PEARLS + D3) and POLYCARBOPHIL CALCIUM (FIBER) for Supplementation therapy, PREGABALIN for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm soreness) and PERIPHERAL SWELLING (arm swollen). On 22-Jan-2021, the patient experienced PRURITUS (itchy), PERIPHERAL SWELLING (swollen 3 inches in size) and ERYTHEMA (redness). On 17-Jan-2021, PAIN IN EXTREMITY (arm soreness) and PERIPHERAL SWELLING (arm swollen) had resolved. At the time of the report, PRURITUS (itchy), PERIPHERAL SWELLING (swollen 3 inches in size) and ERYTHEMA (redness) outcome was unknown. Not provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Head pain; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Head pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced HEADACHE (Head pain). At the time of the report, HEADACHE (Head pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Skin reaction, Vaccination site cellulitis, Vaccination site erythema, Vaccination site induration
Clinical narrative: Delayed reaction; vaccination site cellulitis; Induration at injection site; Redness at injection site; This spontaneous case was reported by a physician and describes the occurrence of SKIN REACTION (Delayed reaction), VACCINATION SITE CELLULITIS (vaccination site cellulitis), VACCINATION SITE INDURATION (Induration at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039k20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN REACTION (Delayed reaction), VACCINATION SITE CELLULITIS (vaccination site cellulitis), VACCINATION SITE INDURATION (Induration at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site). At the time of the report, SKIN REACTION (Delayed reaction), VACCINATION SITE CELLULITIS (vaccination site cellulitis), VACCINATION SITE INDURATION (Induration at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Flushing, Palpitations
Clinical narrative: Flushing on the face; Heart started to race; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Flushing on the face) and PALPITATIONS (Heart started to race) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced FLUSHING (Flushing on the face) and PALPITATIONS (Heart started to race). On 30-Dec-2020, FLUSHING (Flushing on the face) and PALPITATIONS (Heart started to race) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.    No treatment information was provided.